0.00Open0.05Pre Close0 Volume0 Open Interest1.50Strike Price0.00Turnover7743.30%IV-61.02%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.05Time Value100Contract SizeAmericanOptions Type-0.0439Delta0.0428Gamma74.40Leverage Ratio-4.3001Theta0.0000Rho-3.26Eff Leverage0.0000Vega
NRX Pharmaceuticals Stock Discussion
Catching the attention of the pharmaceutical industry and investors alike, NRx Pharmaceuticals (Nasdaq: NRXP), a clinical-stage pharmaceutical company, has announced final clinical trial results showcasing a superior safety profile of NRX-101 over lurasidon...
NRX Pharmaceuticals (Nasdaq:Nrxp) Announces Final Clinical Trial Results: Superior Safety Combined With Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar Depression
No comment yet